TY - JOUR
T1 - Exercise for fatigue in people with cancer during and after active treatment
AU - Ernst, Moritz
AU - Andreas, Marike
AU - Wagner, Carina
AU - Cryns, Nora
AU - Oeser, Annika
AU - Messer, Sarah
AU - Bröckelmann, Paul
AU - Holtkamp, Ulrike
AU - Monsef, Ina
AU - Scherer, Roberta W.
AU - Mishra, Shiraz I.
AU - Skoetz, Nicole
N1 - Funding Information:
We thank Jo Morrison for clinical and editorial advice; Gail Quinn, Clare Jess, and Tracey Harrison for their contribution to the editorial process: and Jo Platt for designing the original, and for reviewing the final, search strategy. We are grateful to the following consumers for their valuable help in prioritising the outcomes: Antje Senger, Sabine Thews, Stefan Tondl, Norbert Meusgeier, and Urich Nikolaus. The authors and Cochrane Gynaecological, Neuro-oncology and Orphan Cancers Team are grateful to peer reviewers Andrew Bryant and Rosa Parisi for their time and comments. The authors would also like to thank the copy-ediotr, Lisa Winer. This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to the Cochrane Gynaecological, Neuro-oncology and Orphan Cancers Group. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, National Health Service, or the Department of Health, United Kingdom.
Funding Information:
This review is funded by the Federal Ministry of Education and Research of Germany (Bundesministerium für Bildung und Forschung (BMBF)), grant number: FKZ 01KG2017.
Funding Information:
Moritz Ernst: hasdeclared that they have no conflict of interest. Marike Andreas: reports a grant form the Federal Ministry of Education and Research, Germany (BMBF grant application, No: 01KG2017); paid to institution. Carina Wagner: reports a grant from the Federal Ministry of Education and Research, Germany (funding number: 01KG2017); paid to institution. Nora Cryns: has declared that they have no conflict of interest. Annika Oeser: has declared that they have no conflict of interest. Sarah Messer: has declared that they have no conflict of interest. Paul Bröckelmann: reports consultancy fees and travel expenses from BeiGene, Bristol-Myers Squibb Foudation, Celgene and Takeda Oncology;paid to himself. Ulrike Holtkamp: has declared that they have no conflict of interest. Ina Monsef: has declared that they have no conflict of interest. Roberta W Scherer: has declared that they have no conflict of interest. Shiraz I Mishra: has declared that they have no conflict of interest. Nicole Skoetz: has declared that they have no conflict of interest.
Funding Information:
This project was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to the Cochrane Gynaecological, Neuro-oncology and Orphan Cancers Group. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, National Health Service, or the Department of Health, United Kingdom.
Publisher Copyright:
Copyright © 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
PY - 2022/3/4
Y1 - 2022/3/4
N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Based on this single protocol, we will conduct five separate reviews, each on one of the following types of exercise. Aerobic exercise Anaerobic exercise Combined (aerobic and anaerobic) exercise Aerobic versus anaerobic exercise Yoga. The primary aims of these reviews are to:. evaluate the effects of aerobic exercise on CRF in people with cancer; evaluate the effects of anaerobic exercise on CRF in people with cancer; evaluate the effects of aerobic and anaerobic (combined) exercise on CRF in people with cancer; compare the effects of aerobic exercise versus anaerobic exercise on CRF in people with cancer; evaluate the effects of yoga on CRF in people with cancer. Furthermore, our aims for each of these reviews are to evaluate the effects at:. different periods of treatment in relation to cancer treatment (before, during, or after treatment); different periods of assessment (up to 12 weeks follow-up, more than 12 weeks to less than 6 months follow-up, or 6 months or longer follow-up). Moreover, we will analyse the effects of exercise on HRQoL, adverse events, depression, and anxiety.
AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Based on this single protocol, we will conduct five separate reviews, each on one of the following types of exercise. Aerobic exercise Anaerobic exercise Combined (aerobic and anaerobic) exercise Aerobic versus anaerobic exercise Yoga. The primary aims of these reviews are to:. evaluate the effects of aerobic exercise on CRF in people with cancer; evaluate the effects of anaerobic exercise on CRF in people with cancer; evaluate the effects of aerobic and anaerobic (combined) exercise on CRF in people with cancer; compare the effects of aerobic exercise versus anaerobic exercise on CRF in people with cancer; evaluate the effects of yoga on CRF in people with cancer. Furthermore, our aims for each of these reviews are to evaluate the effects at:. different periods of treatment in relation to cancer treatment (before, during, or after treatment); different periods of assessment (up to 12 weeks follow-up, more than 12 weeks to less than 6 months follow-up, or 6 months or longer follow-up). Moreover, we will analyse the effects of exercise on HRQoL, adverse events, depression, and anxiety.
UR - http://www.scopus.com/inward/record.url?scp=85126037753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126037753&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD015211
DO - 10.1002/14651858.CD015211
M3 - Article
AN - SCOPUS:85126037753
SN - 1465-1858
VL - 2022
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 3
M1 - CD015211
ER -